Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy R Sterling

Showing results (11-20 of 330) with videos related to

Pageof 33
Sort By:
Clinics in Chest Medicine|November 17, 2019
Treatment of Latent Tuberculosis Infection-An UpdateMoises A Huaman, Timothy R Sterling
The New England Journal of Medicine|July 14, 2006
Transmission of Mycobacterium tuberculosis from health care workersTimothy R Sterling, David W Haas
AIDS Clinical Care|February 13, 2002
Tuberculosis and HIVKaren A Wendel, Timothy R Sterling
Clinics in Chest Medicine|April 20, 2005
Treatment of latent tuberculosis infection: challenges and prospectsKelly E Dooley, Timothy R Sterling
The Journal of Clinical Investigation|August 25, 2020
Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosisTimothy R Sterling, Philana Ling Lin
Current Infectious Disease Reports|September 13, 2017
Tuberculosis MeningitisKassem Bourgi, Christina Fiske, Timothy R Sterling
The New England Journal of Medicine|June 6, 2019
Reply to: "Rifapentine and Isoniazid for Latent Tuberculosis"Timothy R Sterling, Ruth Moro, M. Elsa Villarino
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
HIV infection-related tuberculosis: clinical manifestations and treatmentTimothy R Sterling, Paul A Pham, Richard E Chaisson
BMJ (Clinical Research Ed.)|March 15, 2003
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisTimothy R Sterling, Harold P Lehmann, Thomas R Frieden
Pageof 33

Showing results (11-20 of 330) with videos related to

Sort By:
Pageof 33
Clinics in Chest Medicine|November 17, 2019
Treatment of Latent Tuberculosis Infection-An UpdateMoises A Huaman, Timothy R Sterling
The New England Journal of Medicine|July 14, 2006
Transmission of Mycobacterium tuberculosis from health care workersTimothy R Sterling, David W Haas
AIDS Clinical Care|February 13, 2002
Tuberculosis and HIVKaren A Wendel, Timothy R Sterling
Clinics in Chest Medicine|April 20, 2005
Treatment of latent tuberculosis infection: challenges and prospectsKelly E Dooley, Timothy R Sterling
The Journal of Clinical Investigation|August 25, 2020
Treatment of latent M. tuberculosis infection and use of antiretroviral therapy to prevent tuberculosisTimothy R Sterling, Philana Ling Lin
Current Infectious Disease Reports|September 13, 2017
Tuberculosis MeningitisKassem Bourgi, Christina Fiske, Timothy R Sterling
The New England Journal of Medicine|June 6, 2019
Reply to: "Rifapentine and Isoniazid for Latent Tuberculosis"Timothy R Sterling, Ruth Moro, M. Elsa Villarino
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 11, 2003
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicityTimothy R Sterling, Richard E Chaisson, Richard D Moore
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2010
HIV infection-related tuberculosis: clinical manifestations and treatmentTimothy R Sterling, Paul A Pham, Richard E Chaisson
BMJ (Clinical Research Ed.)|March 15, 2003
Impact of DOTS compared with DOTS-plus on multidrug resistant tuberculosis and tuberculosis deaths: decision analysisTimothy R Sterling, Harold P Lehmann, Thomas R Frieden
Pageof 33